Strangvac has been in development for over 25 years and Dechra says it's the first and only intramuscular vaccine to help protect against strangles.
Strangvac contains recombinant proteins CCE, Eq85 and IdeE from Streptococcus equi and has DIVA (Differentiating Infected from Vaccinated Animals) capability.
The vaccine contains no live bacteria or bacterial DNA, so will not trigger positive culture or PCR tests.
In trials the new vaccine protected more than 94% of horses1.
Dechra says it reduces the clinical signs of strangles including a high temperature, coughing, inappetence, difficulty swallowing and changes in demeanour, while also reducing the number of lymph node abscesses.
Strangvac can be given to foals from five months of age and two injections should be given at a four-week interval.
Horses at high risk of Streptococcus equi infection, such as those in livery, should be revaccinated after two months.
Based on measured antibody titres, immunological memory was found in horses following repeated vaccination six months after primary vaccination.
Dr Andrew Waller, chief scientific officer at Intervacc AB, the company that developed the vaccine, said: “Strangvac is a ground-breaking new vaccine which, alongside good stable management and biosecurity procedures, can play a really important role in improving herd immunity and reducing the number of strangles cases in the equine population, thereby preventing major economic loss to the equestrian industry.”
https://www.dechra.co.uk/equine/vaccines
The one-hour CPD session is being given by Tom Dutton (pictured right), an EBVS specialist in avian medicine and surgery.
Tom said: “We are currently suffering from the biggest avian flu outbreak in UK history.
“As well as the widely reported effect on the UK commercial poultry industry, there have also been a number of cases in captive birds.
“Bird owners are naturally worried about their pets becoming infected and practice vets are also having to field requests from members of the public who are concerned about wild birds.
“This session will help vets to manage enquiries and handle any potential clinical situations with confidence.”
To register for the webinar, email Jess at: GWEReferrals@vets-now.com before 23rd January
The broached bottle must be kept refrigerated between 20C and 80C until the next use.
Virbac says that whilst this may not seem a huge change, it significantly increases the cost-effectiveness and convenience to farmers.
The SPC changes mean that
Bovigen Scour is available in 5 and 30 dose bottles.
A recent survey of nurses attending Hill's nurse roadshows has identified that just over 20 per cent of nurses pay for their own CPD. Although no claims have been made regarding how representative the sample is of the general nursing population, the survey by Hill's Pet Nutrition mirrors the results of a recent RVCS survey.
Adrian Pratt, Veterinary Affairs Manager at Hill's said: "It comes as no great surprise to find that nurses are so dedicated to doing a good job that they will even fund their learning themselves and it's great that round 80 per cent are having their CPD paid for. It is a little depressing to find that some of the practices they work in are unable to support nurses in their efforts, perhaps because of the economic situation. We launched our Veterinary Nutrition Academy with the aim of offering easy to access CPD, free or at very low cost. Practice members can register free and I'd really encourage practice principals and practice managers to take a look at www.myhillspet.com/vna to see how much is available for negligible or very little expenditure. The credit crunch is affecting lots of people and practices but if we can use any down time available to improve skills and knowledge, that has got to be a healthy response."
Bonny Millar, President of the BVNA said: "Some employers may still be unaware that CPD is now compulsory for the RVN but a recent RCVS ‘Survey of the Veterinary Nursing Profession 2008', found that qualified VNs were not finding it difficult to meet the required 45 hours of CPD over 3 years. Those who took part in the survey said that they averaged just over 3 days in the last 12 months, with 84% of those surveyed saying all or most was paid for by the employer. As there is no obligation for the employer to pay for CPD, it is good to know that so many are doing so but it is also important that nurses can demonstrate that any newly gained knowledge will be used to provide a better service to their patients and practice."
This was a view echoed by Sarah Hibbert, President of VPMA: "It would seem logical that relevant CPD which has a benefit to both the practice and individual should be considered in a structured fashion and in light of these findings it would be appropriate for practices revisit their CPD policies to ensure they are fair and reasonable to all parties concerned."
The Hill's survey also showed that just under 30 per cent of nurses have their own CPD allowance provided by the practice. This suggests that about half of the nurses in the UK are to a large extent basing their CPD on self-directed learning. One of the champions of self-directed learning, Malcolm Knowles, defines it as a process ‘... in which individuals take the initiative, with or without the help of others, in diagnosing their learning needs, formulating learning goals, identifying human and material resources for learning, choosing and implementing appropriate learning strategies, and evaluating learning outcomes.'
According to Adrian this could signal a positive step forwards, "On one hand self directed learners have been shown to be more proactive about learning, more motivated and more likely to retain and use what they do learn. However, there is a danger that a practice could be left with gaps in knowledge or skills unless there is some active intervention in the form of a review or guidance regarding the individual's particular training needs, those of the practice team as a whole and the appropriateness of individual courses. Those practices that allocate training allowances are to be congratulated on being forward thinking but it is worth remembering that conferring a training allowance does not involve abrogating responsibility for providing support, guidance and encouragement. We have taken care to introduce incentives for completion of Hill's VNA courses, not because we think that nurses need to be motivated by extrinsic rewards but because we should celebrate those who work hard to become better nurses."
Intervet/Schering-Plough Animal Health has announced the replacement of its Bovilis® IBR with Bovilis® IBR Marker Live vaccine, a move that brings the UK into line with the rest of Europe where marker vaccines are favoured.
Many EU member states, including Scandinavia and Austria are now declared IBR-free, and others (Germany and Hungary) operate national eradication programmes. Using a marker vaccine will help farmers wishing to export animals, or semen, or those working towards an eradication programme in their herds.
Recent bulk milk and blood screening via Intervet/Schering-Plough's complimentary BeefCheck and DairyCheck has revealed that 72% of herds tested were positive for IBR exposure. Given the latent nature of infection, and the rumbling losses associated with subclinical disease, it should come as no surprise that farmers are increasingly interested in controlling IBR. Studies have shown that IBR infection can result in a milk yield reduction of 173 litres per infected animal, or over £400 a year, for a 100-cow herd.
According to Intervet/Schering-Plough, Bovilis IBR Marker Live is Europe's leading IBR vaccine. It can be given intra-muscularly or intra-nasally to calves as young as two weeks old, as well as pregnant dams. It is also licensed to be given together with the pneumonia vaccine Bovilis® Bovipast RSP. The primary course involves one dose in cattle over three months of age, with immunity in just four days from the intra-nasal method, and 14 days from injection. Stock need re-vaccination every six months.
The vaccine reduces the amount of virus excreted into the environment, so minimising the risk to stressed cattle which may have been brought into the herd, and be latently infected. It also makes it an excellent choice for producers with breeding bulls, which should not be vaccinated. Bulls have to be kept naïve, however, the marker vaccine can be used on females in the herd to minimise virus circulation. This way the threat is minimised, and bulls can be kept infection free.
The first issue of the online European Journal of Companion Animal Practitioners (EJCAP) has gone online.
In the issue, which is available exclusively to members of the Federation of European Companion Animal Veterinary Associations (FECAVA), several top European experts on diagnostic imaging present their 'tips and tricks' on radiographic, arthroscopic and ultrasound examination of selected joints and abdominal organs. It also provides an insight into the newer tools of CT and MRI to show how these can help to diagnose some more elusive conditions.
In the issue, you can test your knowledge and watch 'how to' videos, interactive slideshows and dynamic CT scans.
Articles include:
The issue also features book reviews, global and European updates and FECAVA news, with the new poster on the prevention of antibiotic resistance, and a video message from the Russian FECAVA Director Ilya Serada.
If you'd like to register for membership of the FECAVA, visit: www.fecava.org/ejcap and follow the instructions. Once registered and logged in, all EJCAP online and previous print volumes of EJCAP (available in pdf) can be accessed directly.
FECAVA is supported by MSD Animal Health, Hills Pet Nutrition and Elanco Animal Health.
Bimeda has launched Recocam, a 20mg/ml meloxicam preparation licensed for use as a single injection course in cattle, horses and pigs.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "Meloxicam's anti-inflammatory credentials and safety profile is well proven and it remains rightly popular with large animal vets. With our manufacturing expertise it makes sense to add this widely used product to our portfolio. Our aim is to provide a comprehensive range of both established standards and new innovative products for cattle and equine vets, and this is just another step in that process."
Bimeda says Recocam has a broad range of indications including acute respiratory infections, in combination with oral re-hydration in diarrhoea therapy and acute mastitis, for non-infectious locomotor disorders and lameness in pigs and alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders and pain relief associated with equine colic. In cattle Recocam can be given by single subcutaneous or intravenous injection.
Happy Snack is described as a light, delicious creamy snack which contains alpha-casozepine, a natural milk protein with claimed appeasing properties.
In a study conducted by the company, the new treat was taken by 86% of cats.
Happy Snack is suitable for cats and kittens from 12 weeks of age and can be used directly from the sachet, on food or from a finger.
Feline behaviourist, Lucy Hoile, said: “I am very excited about Happy Snack, as I think there is a real gap in the market!
"Something delicious that a person can give easily to a cat, is a great tool to help with general distraction and bond building.”
Happy Snack by Feliway is available in packs of six sachets.
www.feliway.com/uk.
Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses
Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins associated with both inflammation and pain, COX-1 has a pivotal role in maintaining normal physiological function, so inhibiting this enzyme may have an increased risk of side effects e.g. gastric ulceration. Merial says Equioxx is the only NSAID that is highly COX-2 selective (up to 643 times more selective for COX-2 than COX-1), acting to reduce pain and inflammation but without affecting the COX-1 enzyme at therapeutic levels.
Equioxx contains the active ingredient firocoxib, and Merial says it is proven to be effective at reducing chronic lameness in horses. Appearing in blood plasma within 30 minutes of oral dosing, its pharmacokinetic profile allows once daily dosing. Field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.
Equioxx is available as either a low dose injectable solution or a palatable oral paste.
For more information contact Merial Customer Services on 0870 6000 123
During a welcome reception, leaders and representatives of the veterinary profession were given tours of the facility and shown the advanced surgical training and ultrasound equipment available.
The wet-lab is equipped with 13 electrically-adjustable surgical tables, each with their own operating light and an audio-visual (a/v) system connecting them to the lecturer. The a/v system enables the lecturer to carry out demonstrations of procedures and to provide individual or group guidance to delegates practising surgical and other practical techniques.
Delegates are able to use the latest surgical and diagnostic equipment, including IM3 dental equipment, Logic E ultrasound machines and new surgical instrumentation for a range of orthopaedic and soft tissue procedures.
Improve's Managing Director, David Babington MRCVS, said: "Newly qualified vets have a huge need for additional training in practical skills and this demand extends into their ongoing professional life as new techniques are developed and existing ones refined.
"We already offer practical training facilities to delegates attending our training programmes at our HQ in Swindon but wanted to make it easier for vets and nurses in the north of the UK to access these facilities. This new 'wet-lab' offers an ideal training environment for our delegates to accelerate their learning and take new skills back to their practice."
He added: "Learning new techniques, whether surgical or diagnostic, is a proven way to boost practice profitability because it reduces the need to refer more complex cases. We hear from many of those who have trained with us that their increased skillset has enhanced their job satisfaction and increased the volume of cases they treat. In many cases, the training has paid for itself many times over. We are excited at the prospect of helping even more veterinary professionals to advance their skills."
Special interest groups on VetSurgeon are areas where discipline-specific news, forum discussions, CPD events and clinical images are curated in one place. They also help members with shared interests connect with each other and interact with experts in the field.
In the Small Animal Medicine Group, I am delighted to welcome two contributing experts. Firstly, Andy Kent from Willows Referral Centre, who is already well-known on VetSurgeon for his helpful, knowledgeable and thoughtful contributions. Secondly, the pharmacist Andrea Tarr who, as the founder of Veterinary Prescriber, is something of a font of knowledge.
All VetSurgeon members with an interest in small animal medicine are warmly invited to come and join the new group. You need to login, navigate to the section here, and press the 'join' button on the left hand side (you may need to rotate your mobile phone to see it). You can also subscribe to a monthly or weekly digest of content added to the section.
Whilst you're there, I'm going to offer a bottle of good wine (ie not any old plonk) to the member who starts the most interesting discussion in the forum over the next couple of weeks. It could be a general topic, or, better yet, an interesting case discussion. If the latter, it doesn't matter how old it is. If you have an interesting case in your personal archives, dig it out and share it!
Don't forget ... sharing content and contributing to the discussion it starts (or indeed just reading content in the group) can count towards your annual CPD requirement. Just click the 'Claim CPD' button at the top of the page and the system will keep a record of the page you were on, the time you spent and how you found it useful.
The Small Animal Medicine Group is the second special interest group launched so far, after the Small Animal Dentistry Group. Watch this space, there are more on the way ...
Figures produced by the Royal College of Veterinary Surgeons show that almost half of the first cohort of newly-qualified vets to sign up to the Professional Development Phase (PDP) have now completed it.
The PDP is a web-based database that enables new graduates to develop, and reflect on, their professional skills during their first year in clinical practice. Completing the PDP became a professional obligation for all newly-qualified vets from 2007 onwards. Of the 636 vets who graduated in 2007, 586 (92%) signed up to PDP and 290 have now completed. Of the 616 vets who graduated in 2008, 546 (88%) have so far registered for the PDP.
Freda Andrews, RCVS Head of Education, said: "Undertaking PDP is a professional requirement for every newly-qualified vet working in clinical practice. The first vets to undertake PDP seem to be taking around 15 months from signing up to signing off. Properly completing PDP counts as the first year's CPD and we strongly recommend that this year's graduates sign up as soon as they have found their first clinical role."
The PDP is also open to any vet returning to practice.
To find out more about PDP requirements, log onto www.rcvs.org.uk/pdp, to enrol, email pdp@rcvs.org.uk.
The RCVS has announced the candidates standing in the RCVS Council and Veterinary Nurses Council elections this year and is inviting veterinary surgeons and nurses to put their questions to them directly for a video reply.
There are eleven candidates standing for election to RCVS Council in 2015. Overall there are six men and five women, which include two existing Council members eligible for re-election and nine new candidates. They are:
Three veterinary nurses are standing in this year's VN Council elections, including one existing VN Council member eligible for re-election. They are:
Ballot papers and candidates' details are due to be posted to all veterinary surgeons and veterinary nurses eligible to vote during the week commencing 16th March, and all votes must be cast, either online or by post, by 5pm on Friday, 24 April 2015.
Once again the College is inviting members of both professions to 'Quiz the candidates' by putting their questions directly to all those standing for election. Each candidate will then be invited to choose two questions to answer from all those received, and produce a video or audio recording of their answers. All recordings will be published on the RCVS website on Thursday 19 March.
Vets and nurses should email their question (NB one per person) to vetvote15@rcvs.org.uk or VNvote15@rcvs.org.uk, or post it on twitter using the hashtags #vetvote15 or #VNvote15, respectively, by midday on Monday 9 March.
Gordon Hockey, RCVS Registrar said: "It's important that members of the veterinary professions choose who they want to sit on their governing Councils, so we always try to make the elections as interesting and engaging as possible.
"This year, we hope the provision of short videos, to accompany the usual written information, will encourage people to find out a little more about all those standing for election, and then use their vote."
Lizzie Lockett, RCVS CEO, said: “It’s clear that there are a number of workforce issues affecting the professions, such as high vacancy rates that employers are struggling to fill and a resultant increase in pressure on the professions in terms of caseload and hours worked, together with an increase in the number of people choosing to leave the professions.
“While many of these issues are long-standing, and due to complex and multifactorial reasons, the scale of the problem has been exacerbated by three things: the UK’s exit from the EU and the impact this has had on overseas registrants; the ongoing impact of the pandemic in areas such as staff absence and burnout; and an increase in demand for veterinary services.
The reports were published in advance of the College's Workforce Summit, held at the end of November to discuss potential solutions to the problems.
They can be downloaded here: https://www.rcvs.org.uk/news-and-views/events/workforce-summit-2021/
A further report of the Workforce Summit is expected in due course, which the College says will include an action plan with commitments from a range of stakeholders.
The extension will triple the size of the hospital's waiting room and nearly double the number of consultation rooms to seven, including one cat-only consult room and a cat-only waiting area.
The work to improve facilities for felines will also enable NWVS to apply for the International Society of Feline Medicine (ISFM) gold award.
Clinical director Prue Neath said: “This work will serve to further enhance the modern facilities we have on offer and add to our wide range of cutting-edge equipment which is all aimed at delivering the very best of care and treatments to our pet patients.
“We are always looking to expand our expert team and recruit new specialists, clinicians and vet nurses, as well as extending our in-house opportunities for residents and interns to fulfil their veterinary ambitions.
“This work will be another piece in the jigsaw which allows us to meet those ambitions, both in terms of the care we deliver to pets and the opportunities we offer to outstanding clinicians.”
www.nwspecialists.com
Photo: Sarah Hardy, client services team leader at NorthWest Veterinary Specialists
This season, the podcast will explore:
Listeners can also access free, downloadable support resources from the Dômes Pharma Vet Vault—including client handouts, treatment guidelines, and clinical checklists that align with podcast content.
Emma Hancox MRCVS, Technical Vet Advisor at Dômes Pharma said: “Epilepsy cases can be intimidating and challenging for many first-opinion vets.
“Our goal is to make it more approachable, practical, and even enjoyable—by combining expert discussion with down-to-earth advice you can use the next day in practice.”
https://domespharma.co.uk/synaptic-tails-our-neurology-podcast
Royal Canin is offering Dyson Animal handheld bagless vacuum cleaners (normally retailing at £130) with orders of over £500 at Congress this year.
The Royal Canin Veterinary range will be on display, including the latest additions for cats, Renal Special Dry and Renal with Tuna.
Delegates can also find out more about Royal Canin’s programme of on-site in-practice staff training on nutrition, Pet Health Counsellor courses and extensive support material for veterinary nurses, receptionist courses, display material for the waiting room, and a helpline to ensure that vets and their teams have quick access to the most up to date information.
Everyone who drops in on Royal Canin will also be able to enter a free draw to win a flight in a hot air balloon.
A Royal College of Veterinary Surgeons audit panel is to visit UK veterinary schools to assess how Extra-Mural Studies (EMS) is being carried out, identify good practice and make recommendations for improvement. The exercise is part of a package of measures which aims to improve the way that EMS helps veterinary undergraduates to gain skills and knowledge in a practice environment.
RCVS Council agreed to the implementation of proposals made by a Working Party set up to review the whole EMS process in November 2009. While the EMS system was largely agreed to be valuable and working well, some areas were identified for improvement. Many of the recommendations centred on a better understanding amongst all parties involved - students, practices and vet schools - of the aims and objectives of EMS for the student, and improved communication about expectations and outcomes.
As a first step, the Education Policy and Specialisation Committee has put in place an audit of EMS at the veterinary schools. It has commissioned Dr Barry Johnson, who led the original Working Party, together with practitioners David Black, David Wadsworth and Dr Chris Chesney, to follow through individual cases, talking to the students, practitioners and clinical tutors and EMS co-ordinators at the vet schools, to build a picture of how administration, communication and follow-up is managed.
Barry said: "The objective of the audit is to identify areas of good practice that can be shared, and identify where improvements could be made - it will also promote dialogue between practices and the schools. The exercise will be repeated over the next couple of years to track changes."
The first audit took place at the Royal Veterinary College in February, as part of the full RCVS visitation of the undergraduate degree programme. The EMS audit panel will report its initial findings in June.
The full report and recommendations from the EMS Working Party can be viewed at www.rcvs.org.uk/EMS.
CVS has launched a buying group open to independently-owned practices to benefit from the knowledge, experience and strength of the 250 practices which form CVS.
The new buying group is called MiVetClub. It offers a range of services, including:
Sara Armitage, Director of Product and Buying at CVS, said: "There are many thriving independent practices out there which have the potential to be even more successful if they just had the time and expertise to negotiate better deals and had access to the business resources and support to help them run their practices more efficiently and cost-effectively.
"That's where MiVetClub can help. CVS' stature in the veterinary sector means that we can negotiate the very best discounts and rebates for the group's members. But MiVetClub isn't just about saving money. It's also about helping independent practices raise clinical standards and run better businesses. MiVetClub experts are constantly on-hand to advise members on all aspects of running their practice, freeing up their time to concentrate on what they do best, caring for their patients."
For more information, visit: http://www.mivetclub.com/
Dechra Veterinary Products has published a new series of video presentations about the diagnosis and treatment of canine hypoadrenocorticism to help veterinary surgeons who are prescribing Zycortal for the condition.
The six videos, which were recorded by Dechra's technical team, range in length from 10 minutes to 37 minutes.
Episode one describes the pathophysiology of Addison’s disease, different types of Addison’s disease and helps veterinary surgeons recognise the common clinical presentations of chronic hypoadrenocorticism.
Episode two examines the similarities in clinical presentation between hypoadrenocorticism and other disease processes.
The third episode looks at the changes commonly seen in the haematology, biochemistry and urinalysis of Addison’s patients. This section also covers how to perform and interpret hormone testing with the knowledge of the common causes of false positive results.
The fourth looks at a clinical presentation of an acute Addisonian crisis and best practice for emergency treatment of these patients, as well as the transfer of an acute patient onto maintenance treatment with Zycortal.
The final two films explore the treatment and monitoring of a patient on Zycortal and how to switch existing Addisonian patients from fludrocortisone acetate to Zycortal. It also documents the help which is available for those more complex cases.
Dechra Brand Manager Craig Sankey said: "These short films are an important support tool for any veterinary professional who is treating patients with hypoadrenocorticism or who may be presented with cases in their practice.
"Addison’s disease can be very hard to diagnose as it mimics so many other illnesses and we hope these presentations will give insights into a complex disease. The introduction of Zycortal has been a vital development in the treatment of the disease and we hope the new resources will be beneficial to veterinary professionals."
The presentations complement resources that Dechra has already produced for dog owners, including a website -www.myaddisonsdog.co.uk - which provides information and resources to help dog owners understand the condition and monitor their pet's progress.
The requirement to treat animals entering the UK against ticks was dropped in January 2012.
Four years later, in 2016, the UK saw its first cases of Babesia canis in dogs that had not travelled abroad. MSD says it is thought the disease entered the UK carried on ticks from dogs imported from Central, Southern or Eastern Europe where the disease is rife.
Tick Awareness Month aims to highlight the need to use treatments against ticks to protect the health of pets and their owners. Vets and nurses who agree that the campaign is important are urged to write to their local parliamentary candidates explaining why introducing tick control for dogs before, during and after travel abroad is so important.
A sample letter is available on the Big Tick Project website (www.bigtickproject.co.uk).
Amanda Melvin, Marketing Manager at MSD Animal Health said: "With an election looming we want protecting UK pets and borders against non-native ticks to be on the agenda for the new Government team at DEFRA as after June 8th they start to reshape animal health policy in the UK in the build up to Brexit. If you agree that this campaign is important, during Tick Awareness Month you can get involved by writing to your local parliamentary candidates explaining why introducing tick control for dogs before, during and after travel abroad is so important."
The HT Vista device measures heat transfer rate differences between masses and adjacent normal tissues and then processes that data using machine learning algorithms to classify the masses.
The study evaluated a diverse canine population of 299 dogs with 525 cutaneous and subcutaneous masses.
In the study, the device correctly classified 45 out of 53 malignant masses and 253 out of 378 benign masses (sensitivity = 85% and specificity = 67%).
The negative predictive value of the system (i.e., percent of benign masses identified as benign) was 97%.
This study concluded that the data supports the use of the HT Vista device "as a screening tool and decision support tool for the everyday diagnosis of dermal and subcutaneous masses in general practice, enabling clinicians to differentiate between benign lesions and those requiring additional diagnostics".
Liron Levy-Hirsch, Managing Director of HT Vista’s UK subsidiary said: “We are thrilled to have scientific research validating the success of the HT Vista device.
"The veterinary teams who have already adopted the device into their practice are having great success with it, and with the backing of this newly published paper we hope to reach more practices and ultimately save more dog’s lives.”
www.ht-vet.com / www.ht-vista.uk
Reference
The RCVS Charitable Trust has made two 'Blue Sky' grants of £20,000 each for research into feline rotavirus and equine gut bacteria.
One award has been made to Allison German and Kenton Morgan at the University of Liverpool as a Richard Daubney Research Fellowship. This will enable research to be undertaken into the molecular epidemiology and zoonotic potential of feline rotavirus in UK cats.
Allison said: "Feline rotaviruses have been identified in diarrhoeic children in Japan, Italy, Israel and America, but because of limited funding options, there has been no systematic study of rotaviruses in cats, so the prevalence, risk factors and zoonotic potential are unknown. I am pleased that the Trust has recognised the importance of emerging infectious diseases in companion animals and their potential role in animal and human health."
By assessing faecal samples from cats within Cats Protection Adoption Centres in the UK, the study aims to discover the prevalence of rotavirus in this cat population and broadly identify the strains of feline rotavirus that are circulating, including looking for any with identity to human strains. The study will also determine whether the molecular epidemiology of rotavirus in the cat population enables understanding of the diversification and evolution of rotaviruses in people.
A second Blue Sky award of £20,000 has been made to Chris Proudman and Alistair Darby, also at the University of Liverpool, to research the role of gut bacteria in horse health and disease. Called Metagenomic Analytical Utilities for Equines (MANURE), the project will sequence DNA from microbes taken from horse intestines, and analyse the diversity, composition and abundance of the microbial populations. This is expected to improve veterinary understanding of the role of equine gut bacteria, and benefit horses and their owners. Tools being developed to characterise and investigate equine gut microbiota, and findings expected, such as the discovery of novel bacteria, should also be useful to other research.
RCVS Trust Director Cherry Bushell said: "As usual, the standard of applications was very good, although we do continue to receive a relatively high number of applications for projects that the assessors judge to be more 'surveys' than genuine blue sky research.
"In deciding which research to fund, a number of factors are taken into account, such as the quality and strength of the research team, the likelihood of success, and whether a genuine gap in knowledge has been identified. For example, the feline rotavirus research could have important findings in the longer term if it is found that there is genuine risk to human health, and also shows clear potential for further study. Similarly, the equine gut bacteria study is likely to increase considerably knowledge over the longer term and to attract funding from elsewhere for further research."
The Royal Veterinary College is calling for dogs diagnosed with osteoarthritis to take part in a revolutionary study in which their movement will be monitored by a state-of-the-art recorder.
The recorder (pictured right), which is attached to the dog's collar, uses miniaturised sensors based on those found in smart phones. It can distinguish between different activities independent of the dog's location, allowing constant recording of movement in the dog's home environment, to complement the traditional clinical assessments carried out as part of the trial.
The study is being carried out to assess the efficacy of the joint mobility supplement Yumove in reducing the clinical signs of osteoarthritis. This will be the first time that the real effect of a joint supplement has been measured.
Dr. John Howie, co-founder of Lintbells, the company that makes Yumove, said: "This is the first time the real effect of a joint supplement has been measured and it will be a very fast trial. Yumove is a supplement that has been specifically formulated to include glucosamine, chondroitin and Omega 3 from green-lipped mussel, which all work together to increase joint mobility and provide an anti-inflammatory effect."
The research is being led by Dr Matthew Pead the RVC's Academic Director of Professional Assessment and Development. He said: "The results of this study will have important clinical implications for the understanding and treatment of canine OA, with the ultimate aim of advancing the treatment of this difficult and degenerative disease for the benefit of many thousands of dogs."
Any veterinary surgeon with a patient in their practice that might benefit from this study is invited to refer them. Further details are available the Clinical Investigation Centre at the Royal Veterinary College - email cic@rvc.ac.uk or phone 01707 666605.
A new device call the Animalarm, which sends dog owners an SMS text message if the temperature in their car exceeds a preset threshold, has been launched this week.
Apparently, you can also ring the device to check what the temperature is inside your car.
The Animalarm sells for £108 inc. VAT from www.animalarm.co.uk.
Now all we need is a bit of sun.